首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >μO-conotoxin MrⅥB selectively blocks Na_v1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits
【24h】

μO-conotoxin MrⅥB selectively blocks Na_v1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits

机译:μO-芋螺毒素MrⅥB选择性阻断Na_v1.8感觉神经元特异的钠通道和慢性疼痛行为,而无运动功能障碍

获取原文
获取原文并翻译 | 示例
       

摘要

The tetrodotoxin-resistant voltage-gated sodium channel (VGSC) Na_v1.8 is expressed predominantly by damage-sensing primary afferent nerves and is important for the development and maintenance of persistent pain states. Here we demonstrate that μO-conotoxin MrⅥB from Conus marmoreus displays substantial selectivity for Na_v1.8 and inhibits pain behavior in models of persistent pain. In rat sensory neurons, submicromolar concentrations of MrⅥB blocked tetrodotoxin-resistant current characteristic of Na_v1.8 but not Na_v1.9 or tetrodotoxin-sensitive VGSC currents. MrⅥB blocked human Na_v1.8 expressed in Xenopus oocytes with selectivity at least 10-fold greater than other VGSCs. In neuropathic and chronic inflammatory pain models, allodynia and hyperalgesia were both reduced by intrathecal infusion of MrⅥB (0.03-3 nmol), whereas motor side effects occurred only at 30-fold higher doses. In contrast, the nonselective VGSC blocker lignocaine displayed no selectivity for allodynia and hyperalgesia versus motor side effects. The actions of MrⅥB reveal that VGSC antagonists displaying selectivity toward Na_v1.8 can alleviate chronic pain behavior with a greater therapeutic index than nonselective antagonists.
机译:耐河豚毒素的电压门控钠通道(VGSC)Na_v1.8主要通过感觉损伤的传入神经来表达,对于持续性疼痛状态的发展和维持非常重要。在这里,我们证明了来自马孢子的μO-芋螺毒素MrⅥB对Na_v1.8表现出很大的选择性,并在持续性疼痛模型中抑制了疼痛行为。在大鼠感觉神经元中,亚微摩尔浓度的MrⅥB阻断了Na_v1.8特有的河豚毒素抗性电流,但没有阻断Na_v1.9或河豚毒素敏感的VGSC电流。 MrⅥB阻断了非洲爪蟾卵母细胞中表达的人类Na_v1.8,选择性比其他VGSC高至少10倍。在神经性和慢性炎性疼痛模型中,鞘内注射MrⅥB(0.03-3 nmol)可以减轻异常性疼痛和痛觉过敏,而运动副作用仅在高剂量30倍时发生。相比之下,非选择性VGSC阻滞剂利格卡因与运动副作用相比,对痛觉过敏和痛觉过敏没有选择性。 ⅥB先生的作用表明,对Na_v1.8具有选择性的VGSC拮抗剂比非选择性拮抗剂具有更大的治疗指数,可减轻慢性疼痛行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号